
January 31, 2022
Four UNC Lineberger members elected AAAS fellows
Four UNC Lineberger members have been elected 2021 fellows of the American Association for the Advancement of Science, one of the most distinct honors in the scientific community.
January 31, 2022
Four UNC Lineberger members have been elected 2021 fellows of the American Association for the Advancement of Science, one of the most distinct honors in the scientific community.
January 26, 2022
In a laboratory study, UNC Lineberger researchers report a novel combination of two drugs delivered in a nanoparticle formulation may suggest an approach for a less toxic treatment for medulloblastoma, the most common pediatric brain cancer.
January 18, 2022
Pengda Liu, PhD, was awarded the grant to support his research targeting ATR/SPOP signaling to overcome chemotherapy resistance in Ewing sarcoma, a bone cancer that occurs mainly in children.
November 11, 2020
Greg Wang, PhD, and colleagues have identified an evolutionarily conserved pathway responsible for “closing down” gene activity in the mammalian cell.
March 23, 2020
The $125,000 award will support the Liu lab in investigating a specific therapeutic target in basal-like breast cancer, an aggressive breast cancer type.
March 4, 2020
UNC Lineberger members have led e-cigarette research on the potential long-term health effects of vaping and seek effective ways to communicate these risks.
February 6, 2020
Scientists from the UNC School of Medicine, Columbia University, and Rockefeller University have revealed the inner workings of one of the most fundamental and important molecular machines in cells.
January 24, 2020
Researchers at the University of North Carolina Lineberger Comprehensive Cancer Center can illuminate cells from within using an embedded “biological flashlight,” and then use the light to control the cell’s function. In a proof-of-concept study published in the journal ACS Synthetic Biology, researchers describe an advance in “optogenetics,” a field in which scientists use light …
January 13, 2020
A study led by UNC Lineberger's Tim Gershon, MD, PhD, shows new evidence to explain how drug resistance develops in a major subtype of medulloblastoma.
December 16, 2019